TABLE 1.

Clinical Characteristics for Opioid-Exposed Infants With and Without a NAS Diagnosis by a Medical Provider

	Full Study Population	Without NAS Diagnosis	NAS Diagnosis
No. infants	121	93	28
Male, n (%)	58 (47.9)	47 (50.5)	11 (39.3)
Gestational age in wk, median (IQR)	39.0 (37.6–39.6)	38.7 (37.4–39.6)	38.9 (37.8–39.6)
Maternal drug tests positive for 1≥ substances, %	94.5	94.1	96.0
Maximum modified Finnegan score, median (IQR)	7.0 (5.0–10.0)	6.9 (5.0–8.0)	12.5 (10.0–14.3)
LOS in d, median (IQR)	5.0 (5.0–7.0)	5.0 (5.0–6.0)	14.5 (7.8–16.0)